Company Overview and News

9
HUYA / HUYA Inc. FORM S-8

2018-09-14 sec.gov - 3
Form S-8 As filed with the Securities and Exchange Commission on September 14, 2018 Registration No. 333-
HUYA

31
Trade Wars And Tariff Woes: What Do They Mean For Investors?

2018-09-14 seekingalpha - 3
U.S.-China trade talks are tenuous at this point. Where we'll end up on tariffs is uncertain.
WB HUYA IQ UXIN NFLX BIDU

25
Alibaba: Shopping At Firesale Prices

2018-09-13 seekingalpha
Alibaba founder Jack Ma plans to eventually resign from leading the company in September 2019, with Daniel Zhang designated to take over.
BZUN HUYA IQ

85
Is It Time to Buy Alibaba Stock With Both Hands?

2018-09-13 investorplace - 2
Alibaba (NYSE:BABA) has been a hot topic so far this year. June wasn’t that long ago, when Alibaba stock was breaking out to new all-time highs over $210. Since then though, the stock has been under constant pressure for numerous reasons.
JD BABA AMZN IQ HUYA BIDU

7
App Economy Portfolio: A New Marketplace Service On Seeking Alpha

2018-09-10 seekingalpha - 1
Unlock a real-money long-only portfolio built to help investors benefit from the inexorable rise of the App Economy.
HUYA

30
111, Inc. IPO: World's Largest Virtual Pharmacy Network Is Expensive

2018-09-07 seekingalpha - 1
111, Inc. manages 1 Drugstore, which was launched in 2010 and is one of the first online retail pharmacies in China.
BILI HUYA IQ

158
Tracking Chase Coleman's Tiger Global Portfolio - Q2 2018 Update

2018-09-05 seekingalpha - 6
The largest three positions are Spotify, Amazon.com, and JD.com, and they add up to ~30% of the portfolio.
RDFN BCS NOW HUYA REDU FPI CRM QSR.WI SOGO 83SF FEYE AMZN 83SK TWTR MELI SWCH TEAM PSTG COUP BILI CLDR MSFT JD FB FIT LC MDB DOCU NFLX APO ADBE DESP DBX OKTA QSR 47MC SHOP NETS TDG RUN ZTO MA PVTL AVLR V BKNG IQ ADSK FLT

122
Road To Financial Independence: Growing Dividends, Endless Opportunities But Limited Capital

2018-09-03 seekingalpha - 2
The sequential decline is entirely driven by special effects. Endless opportunities in August caused me to trim and sell various smaller holdings.
BZUN HUYA XOM RDSB RDSA EQM AVGO SO CBAUF BABA WCAGY BP JNJ RYDBF JD WFCNP SOJA MOMO NEP ANET WB AAPL CF RYDAF MCD WFC RDS.B RDS.A WRCDF TGT V T PEP IQ SBUX

28
Tracking Robert Karr's Joho Capital Portfolio - Q2 2018 Update

2018-08-20 seekingalpha - 2
The top three positions are Alibaba Group Holdings, Cognex Corporation, and Floor & Décor Holdings. They add up to ~82% of the portfolio.
BABA ALB EL HUYA CGNX HXL FND HXL SBUX FEDU

53
3 Chinese Stocks Not for the Faint of Heart

2018-08-17 investorplace - 4
Chinese stocks are in a bear market. The two largest Chinese internet companies have also entered bear market territory. And the talk of a potential trade war with the largest economy in the world has the Chinese concerned about the future of their economy.
BZUN AMZN HUYA MOMO

7
YY's Mystery Valuation

2018-08-17 seekingalpha - 1
The company produced solid figures but was let down by low Q3 guidance and the shares tanked further.
HUYA

90
How to Trade JD.com Ahead of And After Its Earnings

2018-08-15 investorplace - 1
On August 16th before the open, JD.com (NASDAQ:JD) will report its second-quarter earnings. The company’s shares have not traded well since peaking in June. Will its Q2 results help propel JD stock higher?
JD SOGO BABA AMZN IQ HUYA NFLX BIDU

151
5 Top Stock Trades for Thursday — Buy Alibaba Into Support?

2018-08-15 investorplace - 2
After Tuesday’s reasonable “turnaround,” investors took the full brunt of selling pain on Wednesday, with major indices falling about 1%. Chinese stocks remain under pressure and a big cannabis deal took place. Let’s look at our top stock trades.
JD BABA TWMJF IQ MU HUYA WEED M STZ CGC BIDU

17
YY: 73% Of Value In Tangible Investments And Cash, Extremely Undervalued

2018-08-15 seekingalpha - 4
Bull/bear debate should revolve around the viability of entertainment live streaming over the long-run, which may be negatively impacted by the popularity of short-form video platforms.
HUYA TWTR

39
Tencent Slumps Under Government Wrist-Slap

2018-08-15 seekingalpha - 1
Bottom line: Tencent's (OTCPK:TCEHY) (OTCPK:TCTZF) sudden pulling of a popular game just days after its release shows no one is exempt from Beijing's recent online entertainment clampdown, which could weigh on stocks of related company for the next few months.
IQ HUYA MOMO NTES YY

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...